Database accession: MF7000583
Name: Human migration inhibitory factor-related protein 8
PDB ID: 1mr8
Experimental method: X-ray (1.90 Å)
Assembly: Homodimer
Source organism: Homo sapiens
Primary publication of the structure:
Ishikawa K, Nakagawa A, Tanaka I, Suzuki M, Nishihira J
The structure of human MRP8, a member of the S100 calcium-binding protein family, by MAD phasing at 1.9 A resolution.
(2000) Acta Crystallogr. D Biol. Crystallogr. 56: 559-66
PMID: 10771424
Abstract:
The structure of human MRP8 in the calcium-bound form was determined at 1.9 A resolution by X-ray crystallography. The structure was initially solved by MAD phasing of an ytterbium-substituted crystal and was refined against data obtained from a Ca(2+)-bound crystal. The dimeric form of MRP8 was stabilized by hydrophobic interactions between mutually wrapped helices. There were two EF-hand motifs per monomer and each EF-hand bound one Ca(2+) with a different affinity [the affinity of the C-terminal EF-hand (EF-2) for Ca(2+) was stronger than that of the N-terminal EF-hand (EF-1)]. Furthermore, replacement with Yb(3+) occurred in the C-terminal EF-hand only, suggesting a more flexible nature for EF-2 than for EF-1. This, combined with previous observations that the helix in EF-2 (helix III) undergoes a large conformational change upon calcium binding, suggests that the C-terminal EF-hand (EF-2) plays a role as a trigger for Ca(2+)-induced conformational change.
Molecular function:
arachidonic acid binding arachidonic acid binding
calcium ion binding calcium ion binding
calcium-dependent protein binding calcium-dependent protein binding
microtubule binding microtubule binding
RAGE receptor binding RAGE receptor binding
Toll-like receptor 4 binding Toll-like receptor 4 binding
zinc ion binding zinc ion binding
Biological process:
activation of cysteine-type endopeptidase activity involved in apoptotic process activation of cysteine-type endopeptidase activity involved in apoptotic process
apoptotic process apoptotic process
astrocyte development astrocyte development
autocrine signaling autocrine signaling
autophagy autophagy
chronic inflammatory response chronic inflammatory response
defense response to bacterium defense response to bacterium
defense response to fungus defense response to fungus
inflammatory response inflammatory response
innate immune response innate immune response
leukocyte migration involved in inflammatory response leukocyte migration involved in inflammatory response
neutrophil aggregation neutrophil aggregation
neutrophil chemotaxis neutrophil chemotaxis
peptide secretion peptide secretion
peptidyl-cysteine S-nitrosylation peptidyl-cysteine S-nitrosylation
positive regulation of cell growth positive regulation of cell growth
positive regulation of inflammatory response positive regulation of inflammatory response
positive regulation of intrinsic apoptotic signaling pathway positive regulation of intrinsic apoptotic signaling pathway
positive regulation of NF-kappaB transcription factor activity positive regulation of NF-kappaB transcription factor activity
positive regulation of peptide secretion positive regulation of peptide secretion
regulation of cytoskeleton organization regulation of cytoskeleton organization
regulation of toll-like receptor signaling pathway regulation of toll-like receptor signaling pathway
response to ethanol response to ethanol
response to lipopolysaccharide response to lipopolysaccharide
response to zinc ion response to zinc ion
sequestering of zinc ion sequestering of zinc ion
Cellular component:
calprotectin complex calprotectin complex
collagen-containing extracellular matrix collagen-containing extracellular matrix
cytoskeleton cytoskeleton
cytosol cytosol
extracellular exosome extracellular exosome
extracellular region extracellular region
extracellular space extracellular space
intermediate filament cytoskeleton intermediate filament cytoskeleton
nucleus nucleus
plasma membrane plasma membrane
secretory granule lumen secretory granule lumen
Entry contents: 2 distinct polypeptide molecules
Chains: A, B
Notes: All chains according to the most probable oligomerization state stored in PDBe were considered.
Number of unique protein segments: 1
Name: Protein S100-A8
Source organism: Homo sapiens
Length: 93 residues
Sequence:Sequence according to the corresponding UniProt protein segmentMLTELEKALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETECPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKMGVAAHKKSHEESHKE
UniProtKB AC: P05109 (positions: 1-90)
Coverage: 96%
Name: Protein S100-A8
Source organism: Homo sapiens
Length: 93 residues
Sequence:Sequence according to the corresponding UniProt protein segmentMLTELEKALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETECPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKMGVAAHKKSHEESHKE
UniProtKB AC: P05109 (positions: 1-90)
Coverage: 96%
Representative domain in related structures: S-100/ICaBP type EF hand dimer
Evidence level: Direct evidence
Evidence coverage: The full structure participates in mutual synergistic folding.
Complex Evidence:
GuHCl-induced denaturation of the S100B protein dimer showed that it follows a two-state unfolding/refolding process (PMID:11888280). Other S100 proteins also showed two-state unfolding, no folded monomers were observed (PMID:18346834, PMID:18706914). The dimer has a globular and compact structure with the four helices in each subunit aligning to form a unicornate-type four-helix bundle (PMID:11790100). The hydrophobic core extends through the dimer interface.
Chain A:
N/A
Chain B:
N/A
Surface and contacts features:
Download the CIF file (.cif)
Download this entry's XML file (.xml)
Download this entry's JSON file (.json)